These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27993881)

  • 1. Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
    Rosenbaum ER; Pandey S; Harville TO; Drobena GA; Cottler-Fox M
    Ann Clin Lab Sci; 2016 Dec; 46(6):662-665. PubMed ID: 27993881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Luminex-based single antigen class II bead assay and its mean fluorescence intensity in renal transplant cases; a retrospective observation in 97 cases.
    Pande A; Pandey P; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2020 May; 41(3):322-336. PubMed ID: 32122239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Flow Cytometry-Based Method for Detection of Anti-HLA Complement Activating Donor-Specific Antibodies in Renal Transplant Recipients and Its Comparison With Other Conventional Detection Methods.
    Rani L; Singh H; Saikia B; Aggarwal R; Kumar Y; Kumar M; Chhabra S; Kumar M; Kumar B; Kumar V; Das P; Sharma A; Ramchandran R; Kohli HS; Minz RW
    Transplant Proc; 2023; 55(1):134-139. PubMed ID: 36609023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Renal Transplantation Across HLA Barrier: Report from India.
    Aggarwal G; Tiwari AK; Dorwal P; Chauhan R; Arora D; Dara RC; Kher V
    Indian J Nephrol; 2017; 27(3):210-214. PubMed ID: 28553042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases.
    Pandey P; Pande A; Mandal S; Devra AK; Sinha VK; Bhatt AP; Mishra S
    Transpl Immunol; 2022 Dec; 75():101680. PubMed ID: 35908630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percent cPRA (Calculated Panel Reactive Antibody) Value Predicts Percent of Positive Platelet Crossmatches.
    Pandey S; Rosenbaum E; Cottler-Fox M; Harville TO
    Ann Clin Lab Sci; 2017 May; 47(3):315-318. PubMed ID: 28667033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of donor-specific HLA antibodies: A retrospective observation in 350 renal transplant cases.
    Pandey P; Pande A; Mandal S; Marik A; Devra AK; Sinha VK; Bhatt AP; Gajway SY; Singh RK; Mishra S; Jha S
    Transpl Immunol; 2023 Apr; 77():101783. PubMed ID: 36608831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
    Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
    Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
    Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Luminex-crossmatch assay and its mean fluorescence intensity - a retrospective observation in 380 renal transplant cases.
    Pandey P; Pande A; Mishra S; Setya D; Devra AK; Sinha VK; Bhatt AP
    Pol Przegl Chir; 2022 Apr; 94(2):38-48. PubMed ID: 35485317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups.
    Shroyer TW; Deierhoi MH; Mink CA; Cagle LR; Hudson SL; Rhea SD; Diethelm AG
    Transplantation; 1995 Feb; 59(4):626-30. PubMed ID: 7878769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia.
    Sayed D; Bakry R; El-Sharkawy N; Zahran A; Khalaf MR
    J Clin Apher; 2011; 26(1):23-8. PubMed ID: 21312256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.
    Meneghini M; Melilli E; Martorell J; Revuelta I; Rigol-Monzó E; Manonelles A; Montero N; Cucchiari D; Diekmann F; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
    Kidney Int Rep; 2018 Jul; 3(4):926-938. PubMed ID: 29989033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric detection of complement-activating HLA antibodies.
    Schönemann C; Lachmann N; Kiesewetter H; Salama A
    Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.